スタッフ ログイン
Japanese |
English
ご質問・ご要望
一覧
検索
生物種別閲覧
登録
統計情報
検索
ホーム
一覧
論文
特許
論文 - 一覧
«
»
30 Hits
検索条件 : 絞込み (MeSH = Antineoplastic Combined Chemotherapy Protocols / therapeutic use*)
生物種
リソース名
RRC ID
タイトル
ジャーナル
公開日
外部リンク
ヒト・動物細胞
LC-2/ad(RCB0440)
69599
HADHA is a potential predictor of response to platinum-based chemotherapy for lung cancer.
Asian Pac J Cancer Prev
2011-1-1
Pubmed
ヒト・動物細胞
,
一般微生物
TE-8(RCB2098)
,
TE-10(RCB2099)
,
JCM8532
69461
Fusobacterium nucleatum confers chemoresistance by modulating autophagy in oesophageal squamous cell carcinoma.
Br J Cancer
2021-3-1
Pubmed
Full text
ヒト・動物細胞
HSC-2(RCB1945)
,
Ca9-22(RCB1976)
,
SAS(RCB1974)
65750
Synergetic Effects of PARP Inhibitor AZD2281 and Cisplatin in Oral Squamous Cell Carcinoma in Vitro and in Vivo.
Int J Mol Sci
2016-2-24
Pubmed
Full text
ヒト・動物細胞
Y79(RCB1645)
,
WERI-Rb-1(RCB2146)
65505
Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines.
Curr Eye Res
2015-1-1
Pubmed
Full text
ヒト・動物細胞
PK-8(RCB2700)
,
KLM-1(RCB2138)
64323
Cancer-Specific Targeting of Taurine-Upregulated Gene 1 Enhances the Effects of Chemotherapy in Pancreatic Cancer.
Cancer Res
2021-4-1
Pubmed
Full text
ヒト・動物細胞
HHUA(RCB0658)
64171
PK11195 enhances chemosensitivity to cisplatin and paclitaxel in human endometrial and ovarian cancer cells.
Int J Mol Med
2010-1-1
Pubmed
ヒト・動物細胞
ACC-MESO-1(RCB2292)
,
ACC-MESO-4(RCB2293)
63794
Combined use of irinotecan and p53 activator enhances growth inhibition of mesothelioma cells.
FEBS Open Bio
2020-11-1
Pubmed
Full text
ヒト・動物細胞
HCT116(RCB2979)
58602
KRT17 as a prognostic biomarker for stage II colorectal cancer.
Carcinogenesis
2020-7-10
Pubmed
Full text
遺伝子材料
Genome Network Project Human cDNA Clone IRAL004L19 (HGY081883)
58153
JMJD2A sensitizes gastric cancer to chemotherapy by cooperating with CCDC8.
Gastric Cancer
2020-5-1
Pubmed
Full text
ヒト・動物細胞
StromaNKtert(RCB2350)
56923
Bruton's tyrosine kinase inhibition increases BCL-2 dependence and enhances sensitivity to venetoclax in chronic lymphocytic leukemia.
Leukemia
2017-10-1
Pubmed
Full text
ヒト・動物細胞
HuH-7
56034
Phospho-ERK is a biomarker of response to a synthetic lethal drug combination of sorafenib and MEK inhibition in liver cancer.
J Hepatol
2018-11-1
Pubmed
Full text
ヒト・動物細胞
SLVL(RCB1702)
54875
Combination lenalidomide-rituximab immunotherapy activates anti-tumour immunity and induces tumour cell death by complementary mechanisms of action in follicular lymphoma.
Br J Haematol
2019-4-1
Pubmed
Full text
ヒト・動物細胞
TFK-1(RCB2537)
52691
Combined Gemcitabine and Metronidazole Is a Promising Therapeutic Strategy for Cancer Stem-like Cholangiocarcinoma.
Anticancer Res
2018-5-1
Pubmed
Full text
ヒト・動物細胞
TE-11(RCB2100)
52422
High Expression of the Mitophagy-Related Protein Pink1 is Associated with a Poor Response to Chemotherapy and a Poor Prognosis for Patients Treated with Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Ann Surg Oncol
2017-12-1
Pubmed
Full text
ヒト・動物細胞
LM8(RCB1450)
52367
The effect of immune checkpoint inhibitors on lung metastases of osteosarcoma.
J Pediatr Surg
2017-12-1
Pubmed
Full text
ヒト・動物細胞
StromaNKtert(RCB2350)
45032
Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells.
Blood
2014-6-12
Pubmed
Full text
ヒト・動物細胞
PC-9(RCB4455)
45025
Clinical outcome according to the level of preexisting epidermal growth factor receptor T790M mutation in patients with lung cancer harboring sensitive epidermal growth factor receptor mutations.
Cancer
2014-7-15
Pubmed
Full text
ヒト・動物細胞
U251(RCB0461)
44259
Combination therapy of cilengitide with belotecan against experimental glioblastoma.
Int J Cancer
2013-8-1
Pubmed
Full text
ヒト・動物細胞
ACC-MESO-4(RCB2293)
43801
SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
Int J Cancer
2013-1-15
Pubmed
Full text
ヒト・動物細胞
43666
Combination therapy for hepatocellular carcinoma: additive preclinical efficacy of the HDAC inhibitor panobinostat with sorafenib.
J Hepatol
2012-6-1
Pubmed
Full text